A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
Kestrel Therapeutics, Inc.
Kestrel Therapeutics, Inc.
National Cancer Institute (NCI)
University of California, Irvine
Alterome Therapeutics, Inc.
Pheon Therapeutics
Orano Med LLC
RasCal Therapeutics, Inc.
Xencor, Inc.
Cartography Biosciences
Pfizer
National Institutes of Health Clinical Center (CC)
ALX Oncology Inc.
Northwell Health
Pfizer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Chongqing Precision Biotech Co., Ltd
Medigen Biotechnology Corporation
Revolution Medicines, Inc.
GONGCHU Biotechnology Co., Ltd
Columbia University
Sapience Therapeutics
Sichuan University
Second Affiliated Hospital of Guangzhou Medical University
Aurigene Discovery Technologies Limited
Chongqing Precision Biotech Co., Ltd
Chongqing Precision Biotech Co., Ltd